12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga·07/25/2025 21:06:49

Listen to the news

Gainers

Molecular Partners (NASDAQ:MOLN) shares moved upwards by 11.9% to $4.33 during Friday's after-market session. The market value of their outstanding shares is at $147.4 million.
Ekso Bionics Holdings (NASDAQ:EKSO) shares increased by 7.88% to $5.2. The company's market cap stands at $11.1 million.
Insight Molecular (NASDAQ:IMDX) shares rose 5.7% to $3.05. The market value of their outstanding shares is at $84.6 million.
Akso Health (NASDAQ:AHG) shares increased by 5.0% to $2.1. The market value of their outstanding shares is at $701.9 million.
Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock moved upwards by 4.97% to $27.64. The company's market cap stands at $1.9 billion.
Ernexa Therapeutics (NASDAQ:ERNA) shares increased by 4.61% to $2.04. The company's market cap stands at $15.4 million.

Losers

Calidi Biotherapeutics (AMEX:CLDI) shares fell 13.1% to $0.63 during Friday's after-market session. The company's market cap stands at $26.6 million.
Healthcare Triangle (NASDAQ:HCTI) stock decreased by 8.76% to $0.06. The company's market cap stands at $22.1 million.
Reshape Lifesciences (NASDAQ:RSLS) stock declined by 6.46% to $2.32. The company's market cap stands at $6.5 million.
Aptorum Group (NASDAQ:APM) shares decreased by 5.53% to $1.71. The market value of their outstanding shares is at $12.5 million.
HCW Biologics (NASDAQ:HCWB) stock decreased by 5.4% to $4.03. The company's market cap stands at $8.8 million.
Onconetix (NASDAQ:ONCO) stock decreased by 5.26% to $3.97. The market value of their outstanding shares is at $1.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English